Okay, let's tackle this question. The patient is on insulin and acarbose for diabetes and developed hypoglycemia. The question is asking what treatment to use. Hmm, I remember that acarbose is an alpha-glucosidase inhibitor, which works by delaying carbohydrate absorption in the intestines. So if someone is hypoglycemic and on acarbose, the usual treatment with glucose might not work as effectively because the drug blocks glucose absorption.

Wait, right, the standard treatment for hypoglycemia is glucose, but if acarbose is blocking that, then maybe they need something else. The options probably include glucose, but the correct answer might be glucagon. Because glucagon works by stimulating glycogenolysis in the liver, bypassing the need for intestinal glucose absorption. So in patients on acarbose, glucagon would be the better choice. Let me check the options again. The correct answer should be glucagon.

Now, the other options might include things like dextrose, oral glucose, or maybe even other drugs. For example, if an option is oral glucose, that's not effective here because acarbose inhibits its absorption. So the wrong options would be those that rely on oral glucose. The correct answer is glucagon, which is injectable and works through a different pathway. I need to make sure the explanation covers why glucagon is the right choice and why the others are wrong because they depend on intestinal absorption. Also, the clinical pearl would be that in hypoglycemia with acarbose use, glucagon is preferred over oral glucose.

**Core Concept:**
Acarbose, an alpha-glucosidase inhibitor, delays carbohydrate absorption in the small intestine. During hypoglycemia in patients on acarbose, oral glucose is less effective due to impaired intestinal glucose uptake, necessitating alternative treatments that bypass this pathway.

**Why the Correct Answer is Right:**
Glucagon is the preferred treatment for hypoglycemia in patients taking acarbose. It acts on hepatic glycogenolysis via the glucagon receptor, directly releasing stored glucose into the bloodstream. This mechanism is independent of intestinal glucose absorption, making it effective even with alpha-glucosidase inhibition. Intramuscular or subcutaneous glucagon administration bypasses the gastrointestinal tract entirely.

**Why Each Wrong Option is Incorrect:**
**Option A:** Oral glucose (e.g., dextrose gel) is ineffective because acarbose blocks alpha-glucosidase enzymes, preventing carbohydrate breakdown and absorption in the jejunum.
**Option B:** Intravenous dextrose may be delayed in action due to acarbose’s effect on hepatic glucose release, though it can still partially work. However, glucagon is faster and more reliable in this context.
**Option D:** Insulin (e.g., discontinuation) is irrelevant here—the patient is already hypoglycemic from insulin use, so this would worsen the condition.

**Clinical Pearl / High-Yield Fact:**
Never rely on oral glucose for hypoglycemia in patients on acarbose or other alpha-glucosidase inhibitors (e.g., miglitol). Glucagon is the first-line treatment in such cases. Remember: **"Acarbose blocks the gut—glucagon fixes the blood."**

**Correct

✓ Correct Answer: C. Glucose